Tata Chemicals Ltd

The transcript provided from Tata Chemicals Limited's Q3 and 9MFY26 earnings call does not explicitly mention details regarding the current or expected order book or pending orders. The discussion mainly focuses on: - Industry demand and pricing challenges in soda ash markets globally. - Operational and cost management strategies. - Capacity expansions and their expected impact. - Market-specific challenges like the one-off production issue in the UK. - Export dynamics and regional market performance (US, UK, India, Kenya, Southeast Asia). No direct references or figures pertaining to current order book or pending orders are disclosed in the available transcript pages.

- There is no explicit mention of any new fundraising through debt or equity in the provided transcript. - The company emphasizes cost discipline, reduced CAPEX, and being cash-focused in operations. - It has sharply reduced CAPEX expenditure compared to the previous year and plans further reductions next year. - No new debt or equity issuance is indicated; the focus is on utilizing existing resources efficiently. - The acquisition of Novabay Singapore was through a share purchase agreement, but no details of fresh fundraising related to this are mentioned. - Overall, the company is prioritizing balance sheet strength and cash flow management without indicating current or near-term plans for raising new debt or equity.

- Approved INR 515 crore for a greenfield iodized salt facility in India with 210 KT capacity. - INR 775 crore for 50 KT precipitated silica expansion at Cuddalore, India. - INR 135 crore for 350 KT dense ash plant reconfiguration in Mithapur, India. - Valinokkam facility in Tamil Nadu expected commissioning over next 36 months. - Kenya: Additional 50 KT electric calciner soda ash plant operational by March 2026. - Novabay Singapore acquisition to expand premium bi-carb market in Asia, with potential to double capacity from 60 KT to 120 KT. - Focus on low CAPEX, high-return capacities, mainly in India. - No new CAPEX in US or UK; focus on cost discipline, operational efficiency, and rationalizing capital. - Ongoing strategic pivot to value-added, non-cyclical products with low CAPEX and higher margins.

- Tata Chemicals expects medium-term modest growth in soda ash demand, driven by solar glass and stable consumption in other applications. - India shows relatively robust demand growth, with ongoing capacity expansions in salt, silica, and soda ash focused on premium and higher-margin products. - The U.K. pharmaceutical salt unit is increasing capacity utilization, contributing to future revenue. - Kenya’s new 50,000-tonne electric calciner soda ash plant will boost higher-margin volume from Q4 FY26. - Novabay Singapore acquisition expands presence in the Asian premium bi-carb market, supporting growth. - Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand. - Global markets like China and U.S. show flat or marginal demand declines, but Tata Chemicals focuses on resilient markets and cost discipline. - Overall volume growth in India and Kenya noted; U.S. exports to Southeast Asia temporarily paused but volumes held in other markets.

- Tata Chemicals expects to achieve guided EBITDA of INR 250 crores for FY26, targeting a quarterly EBITDA run rate of about INR 60-65 crores with positive PAT, though currently behind schedule by six months due to operational disruptions. - Cost discipline, fixed cost savings, and operational efficiencies are key focus areas to improve EBITDA and profitability, with part of the turnaround expected to complete in Q4FY26 and fully realized in the next fiscal year. - Expansion plans in India (salt, soda ash, silica) are aimed at moderate CAPEX with high returns (16-18%), contributing to future profit growth. - The Kenya capacity addition (50,000 tonnes electric calciner) is expected to yield higher margins due to a purer product and lower carbon footprint. - The Novabay Singapore acquisition will strengthen presence in premium bi-carb markets in Asia, expected to add operational benefits and geographic diversification. - Market challenges persist, but strategic focus on non-cyclical capacities, lower CAPEX, and cash-focused operations underpin confidence in earnings recovery and growth.